Newbridge Pharmaceuticals
Sandra Reda

Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals

  Cairo, Egypt

About me

PV professional with extensive experience in drug safety, quality assurance, and compliance across 14 MENA regions for 5 years. Skilled in case management, PV audits, medical literature screening, and regulatory documentation

Schedule

My Session

Panel Discussion: Beyond Compliance: Building a Proactive Drug Safety Culture

How leading organisations are embedding pharmacovigilance into decision-making, culture, and strategy - moving from reactive compliance to proactive patient safety.

  • How can pharmacovigilance move from a compliance function to a strategic driver of patient safety?
  • What does true cross-functional ownership of drug safety look like in practice?
  • Are current KPIs driving the right behaviours or just ticking boxes?
  • How can leadership create accountability for proactive safety decisions?

Quality Assurance
Patient Safety
Global Pharmacovigilance

Michael Ramcharan

Managing Director at Reumat Consulting

Ivana Hezoucky

Regional Patient Safety Manager at Boehringer Ingelheim

Judy Barretto

Senior Director at Gilead Sciences

Sandra Reda

Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals

Brian Edwards

Managing Director at Husoteria Ltd

PV oversight over Third-parties

Sandra Reda

Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals


Pharmacovigilance Outsourcing
Quality Assurance
PV Audits & Inspections
Panel Discussion - Leading Pharmacovigilance in a Changing Landscape: What Needs to Evolve Next?

A discussion on how leadership in pharmacovigilance is evolving in response to increasing data, regulatory expectations, and technological change.

  • What are the biggest shifts you’re seeing in pharmacovigilance today?
  • How is the role of PV leaders changing within organisations?
  • What capabilities will future PV teams need to succeed?
  • Where should organisations focus to stay ahead in this evolving landscape?

Quality Assurance
Patient Safety
Global Pharmacovigilance
Adverse Drug Reactions

Michael Ramcharan

Managing Director at Reumat Consulting

Puja Myles

Director, Clinical Practice Research Datalink at Medicines and Healthcare products Regulatory Agency

Joanne Rogerson

Director of Operations at Resolver

Sandra Reda

Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals

Jean-Marc C. Haeusler

Global Head International Patient Safety at Roche

Aliki Taylor

Executive Director, RWE TA Head - Oncology at Gilead Sciences